Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Mar 21;13:818522. doi: 10.3389/fneur.2022.818522

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Ling, Chen, He, Feng, Weng, Cheng, Rong and Xie.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

A heat map of 11 treatment drugs studied in patients with SCI with neuropathic pain for 5 outcomes. Each column represents a treatment drug, and each row represents an outcome. For each outcome (Column 1), the number of studies included in the analysis is presented in parentheses. SUCRA, surface under the cumulative ranking curve. Each box is colored according to the mean SUCRA value of the corresponding treatment and outcome. The color scale consists of values that represent mean SUCRA, which ranges from 0 (red, indicating a treatment is always last) to 1 (green, indicating a treatment is always first). Uncolored boxes labeled NA (data not available) show that the underlying treatment was not included for that particular outcome. The values in each box represent the mean SUCRA value and mean rank of the corresponding drug and outcome.